UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB/A

                                (Amendment No. 1)

                   QUARTERLY REPORT PURSUANT TO SECTION 13 OR
                     15(d) OF THE SECURITIES EXCHANGE ACT OF
                                1934, AS AMENDED:

                For the Quarterly Period Ended September 30, 2005



                         ------------------------------

                          Commission File No. 02-27569

                         ------------------------------

                             NATURAL NUTRITION, INC.
                     (Formerly CSI Business Finance, Inc.)
                           --------------------------
                      (Exact Name Of Small Business Issuer)

                 NEVADA                                65-0847995
                 ------                                ----------
     (State or Other Jurisdiction        (I.R.S. Employer Identification Number)
   of Incorporation or Organization)

   109 North Post Oak Lane, Suite 422
           Houston, Texas                                 77024
           --------------                                 -----
  (Address of Principal Executive Offices)             (Zip Code)

Issuer's telephone number, including area code       (713) 621-2737
                                                     --------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                                 Yes [x] No [ ]

Indicate  by check mark  whether  the  registrant  has filed all  documents  and
reports  required  to be  filed by  Section  12,  13 or 15(d) of the  Securities
Exchange Act of 1934 subsequent to the  distribution of securities  under a plan
confirmed by a court.

                                 Yes [x] No [ ]

The number of shares of common stock issued and  outstanding as of September 30,
2005 was 157,191,508.

Transitional Small Business Disclosure Format (check one).

                                 Yes [ ] No [x]


                                      -1-

<PAGE>

EXPLANATORY NOTE

Natural Nutrition Inc., formerly CSI Business Finance,  Inc., (the "Company") is
filing  this  Amendment  No. 1 to its  Quarterly  Report on Form  10-QSB for the
quarter  ended  September  30,  2005  to  restate  the  financial  results.  The
restatement  includes adjustments to (a) correct the overstatement of the number
of  shares  outstanding,   (b)  to  remove  the  beneficial  conversion  feature
previously  recorded  for  the  convertible  debentures,  and  (c)  correct  the
accounting for  convertible  debentures to recognize the effects of derivatives.
The information contained in this Amendment,  including the financial statements
and the notes hereto, amends Items 1, 2 and 3 of Part I and Item 2 of Part II of
the Company's  originally  filed Quarterly Report on Form 10-QSB for the quarter
ended September 30, 2005 and no other items in its originally  filed Form 10-QSB
are amended hereby.  In accordance  with Rule 12b-15 of the Securities  Exchange
Act of 1934, the complete text of those items in which amended  language appears
is set forth  herein,  including  those  portions of the text that have not been
amended  from  that set  forth  in the  original  Form  10-QSB.  Except  for the
restatement,  this Form  10-QSB/A  does not  materially  modify or update  other
disclosures  in the original Form 10-QSB,  including the nature and character of
such disclosure to reflect events  occurring after November 21, 2005, the filing
date of the original Form 10-QSB.  Accordingly this Form 10-QSB/A should be read
in  conjunction  with the Company's  other filings made with the  Securities and
Exchange  Commission.  Currently dated  certifications  from the Company's Chief
Executive  Officer and Chief Financial Officer have been included as exhibits to
this amendment.

                                      -2-
<PAGE>


                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                     (Formerly CSI Business Finance, Inc.)

                                 FORM 10-QSB/A

                                (Amendment No. 1)

                                      INDEX

PART I- FINANCIAL INFORMATION


ITEM 1. FINANCIAL STATEMENTS                                              Page
                                                                         -------
Unaudited Consolidated Balance Sheet as of September 30, 2005 - Restated    4

Unaudited Consolidated Statements of Operations for the Nine Months
and Three Months Ended September 30, 2005 - Restated                        5

Unaudited Consolidated Statements of Cash Flows for the Nine Months
Ended  September 30, 2005 - Restated                                        6

Notes to Unaudited Consolidated Financial Statements as of
September 30, 2005 - Restated                                               7

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
        AND RESULTS OF OPERATIONS                                           12

ITEM 3. CONTROLS AND PROCEDURES                                             15


PART II- OTHER INFORMATION                                                  16


ITEM 1. LEGAL PROCEEDINGS                                                   16
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS         16
ITEM 3. DEFAULTS UPON SENIOR SECURITIES                                     16
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS                 16
ITEM 5. OTHER INFORMATION                                                   16
ITEM 6. EXHIBITS                                                            17

SIGNATURES                                                                  20


                                       -3-

<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                     (Formerly CSI Business Finance, Inc.)
                      UNAUDITED CONSOLIDATED BALANCE SHEET
                               SEPTEMBER 30, 2005
                                    RESTATED
<TABLE>
<CAPTION>

                                     ASSETS
                                     ------

CURRENT ASSETS
<S>                                                                     <C>
 Cash and cash equivalents                                               $  4,774,914
 Notes receivable                                                             440,592
 Accounts receivable-other                                                     62,379
 Deferred financing costs                                                     191,665
 Derivative asset                                                              31,936
 Investment in marketable securities                                          160,315
 Prepaid and accrued interest                                                  36,490
 Minimum lease payments receivable                                            148,260
                                                                         ------------
 Total current assets                                                       5,846,551
                                                                         ------------
NONCURRENT ASSETS
 Minimum lease payments receivable                                            170,396
 Convertible debenture receivable--net of debenture premium of $32,483      8,467,517
 Notes receivable                                                             500,000
 Fixed assets, net                                                                750
 Deferred financing costs                                                     372,308
 Intangible assets, net                                                        24,787
                                                                         ------------
 Total noncurrent assets                                                    9,535,758
                                                                         ------------
TOTAL ASSETS                                                             $ 15,382,309
                                                                         ============
                     LIABILITIES AND SHAREHOLDERS' DEFICIT
                     -------------------------------------

CURRENT LIABILITIES
 Accounts payable                                                              12,657
 Accrued liabilities                                                          269,059
 Notes payable                                                                463,344
 Unearned income                                                               57,882
                                                                         ------------
Total current liabilities                                                     802,942
                                                                         ------------
NONCURRENT LIABILITIES
 Convertible debenture payable-net of discount of $405,402                 15,229,797
 Derivative liability                                                         405,385
 Accrued interest payable-noncurrent                                           44,978
 Unearned income                                                               29,568
                                                                         ------------
 Total noncurrent liabilities                                              15,709,728
                                                                         ------------
COMMITMENTS AND CONTINGENCIES                                                      --

SHAREHOLDERS' DEFICIT

 Preferred stock, 10,000,000 shares authorized, par value $.01:
  Preferred stock Series A Convertible, 100,000 issued and
   outstanding; no liquidation or redemption value                              1,000
 Common stock, 5,000,000,000 authorized shares, par value $.001
    157,191,508 issued and outstanding                                        157,191
 Retained deficit                                                          (1,288,552)
                                                                         ------------
 Total shareholders' deficit                                               (1,130,361)
                                                                         ------------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                              $ 15,382,309
                                                                         ============
</TABLE>

See accompanying Notes to Consolidated Financial Statements

                                      -4-
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                     (Formerly CSI Business Finance, Inc.)
                 UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
                                    RESTATED

<TABLE>
<CAPTION>

                                                   Nine Months      Three Months
                                                  Ended September  Ended September
                                                      30, 2005         30, 2005
                                                    ------------    ------------
REVENUE

<S>                                                 <C>             <C>
 Lease income                                        $     60,649    $     19,338
 Fee income                                                81,492          34,379
 Trading gains                                             33,898          33,898
                                                     ------------    ------------
 Total revenue                                            176,039          87,615
                                                     ------------    ------------
OPERATING EXPENSES                                            --
 Salaries and benefits                                    230,803         198,697
 Commissions                                                4,521             693
 Business development, travel and entertainment            17,136          16,502
 Depreciation and amortization                              8,830           2,943
 Rent                                                       8,783           6,389
 Professional fees                                         56,464          45,667
 Other                                                     15,890           5,019
                                                     ------------    ------------
 Total expenses                                           342,427         275,910
                                                     ------------    ------------
OTHER (INCOME) EXPENSE
 Interest expense                                          76,081          76,081
 Net change in fair value of derivatives                   (6,839)         (6,839)
 Interest income                                          (29,872)        (29,872)
 Other expense                                             34,557          30,547
 Merger expense                                           876,150         876,150
                                                     ------------    ------------
 Total other expense                                      950,077         946,067
                                                     ------------    ------------
 Loss before provision for income taxes                (1,116,465)     (1,134,362)
INCOME TAX PROVISION                                           --              --
                                                     ------------    ------------
NET LOSS                                               (1,116,465)     (1,134,362)
 Preferred dividends paid                                  12,000              --
                                                     ------------    ------------

LOSS APPLICABLE TO COMMON SHARES                     $ (1,128,465)   $ (1,134,362)
                                                     ============    ============

 Net loss per share for basic and diluted            $      (0.06)   $      (0.06)
                                                     ============    ============
 Weighted shares outstanding for basic and diluted     17,466,612      17,466,612
                                                     ============    ============
</TABLE>

See accompanying Notes to Consolidated Financial Statements

                                      -5-

<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                     (Formerly CSI Business Finance, Inc.)
                 UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS
                  FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2005
                                    RESTATED

<TABLE>
<CAPTION>

CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                            <C>
 Net loss                                                                       $ (1,116,465)
 Adjustment to reconcile net loss to net cash
 provided by (used in) operating activities:
   Depreciation and amortization                                                        8,830
   Amortization of deferred expenses                                                   11,557
   Non-cash expense for redemption of preferred stock                                  40,000
   Non-cash revenues                                                                  (60,648)
   Non-cash expenses                                                                  244,066
   Non-cash merger expense                                                            876,150
 (Increase) decrease in assets:
   Other accounts receivable                                                          (39,199)
   Notes receivable                                                                  (417,790)
   Prepaid and other                                                                  (31,498)
   Investment in marketable securities                                               (160,315)
  Increase (decrease) in liabilities:
   Accounts payable                                                                     3,587
   Accrued liabilities                                                                 82,837
                                                                                -------------
    Net cash used in operating activities                                            (558,888)
                                                                                -------------
CASH FLOWS FROM INVESTING ACTIVITIES
  Purchases of fixed assets                                                            (1,000)
  Change in minimum lease payments receivable                                         (25,037)
                                                                                -------------
    Net cash used in investing activities                                             (26,037)
                                                                                -------------
CASH FLOWS FROM FINANCING ACTIVITIES
  Net proceeds from sale of convertible debentures                                  5,371,839
  Preferred dividends paid                                                            (12,000)
                                                                                -------------
    Net cash provided by financing activities                                       5,359,839
                                                                                -------------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                                4,774,914
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD                                             --
                                                                                -------------
CASH AND CASH EQUIVALENTS, END OF PERIOD                                        $   4,774,914
                                                                                =============
SUPPLEMENTAL INFORMATION
  Interest paid                                                                 $       2,755
  Taxes paid                                                                               --
  Assets and liabilities assumed in merger:
   Prepaids and other                                                                   9,992
   Accounts payable and accrued liabilities                                           262,231
   Convertible debentures and notes payable                                           547,533
   Accrued interest payable                                                            73,244
  Issuance of Series A Convertible Preferred Stock                                      1,000
  Payment of debentures, notes payable and accrued interest                           635,119
  Derivative liability                                                                413,603
  Derivative asset                                                                     33,315
  Discount on debenture payable                                                       413,603
  Premium on debenture receivable                                                      33,315
  Conversion of advances from parent to note payable                                    4,134
  Assets acquired and liabilities paid from proceeds of convertible debenture:
   Debenture, notes payable and accrued interest acquired                           9,000,000
   Deferred expenses                                                                  575,000
   Debenture, notes payable and accrued interest paid                                 635,199
   Accounts payable                                                                    53,161
</TABLE>

See accompanying Notes to Consolidated Financial Statements

                                      -6-
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                     (Formerly CSI Business Finance, Inc.)
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                            AS OF SEPTEMBER 30, 2005
                                    RESTATED

NOTE 1 - DESCRIPTION OF MERGER AND RELATED EVENTS

On August 25, 2005, CSI Business Finance,  Inc., a Nevada corporation  (formerly
Health Express USA, Inc., a Florida  Corporation,  and herein referred to as the
"Company")  completed the closing of that certain Share Exchange  Agreement,  by
and between the Company, CSI Business Finance,  Inc., (the Texas corporation and
now  wholly-owned  subsiding of the Company herein referred to as "CSI") and the
shareholder of CSI (the "CSI Shareholder").

On August 25, 2005, the Company  effectively  exchanged with the CSI Shareholder
the issued and outstanding common stock of CSI in exchange for 100,000 shares of
Series A Convertible Preferred Stock, par value $0.01 per share, of the Company,
and CSI  became a  wholly-owned  subsidiary  of the  Company.  Each share of the
Company's  Series A Preferred Stock is convertible  into 19,500 shares of common
stock of the Company. The Preferred shares were subsequently  distributed to the
shareholders of Corporate  Strategies,  Inc., the former  shareholder of CSI. In
addition,  at the  exchange  date,  110,206,883  shares of  common  stock of the
Company  were  issued  to  pay  off  notes  and  debentures.  If  the  preferred
shareholders were to convert to common stock as of the date of the merger,  they
would hold  1,950,000,000  shares, or ninety-two and one half percent (92.5%) of
the  issued  and  outstanding  shares  of  common  stock  of the  Company.  This
conversion  would  result in the  Series A  Preferred  Shareholders  effectively
controlling the Company.

The Series A Convertible  Preferred  Shareholders  and the holders of the common
stock  of the  Company  vote  together  and  not as  separate  classes,  and the
Preferred Stock shall be counted on an "as converted" basis,  thereby giving the
Preferred  Shareholders  control  of  the  Company.  The  transaction  is  being
accounted for as a reverse  acquisition  since control of the Company has passed
to the shareholders of the acquired company (CSI).

NOTE 2 - NATURE OF OPERATIONS

CSI, the operating  entity of the Company,  was  incorporated  primarily for the
purpose  of  engaging  in  equipment  leasing.  Subsequent  to the  merger,  the
Company's  consolidated  operations  have  expanded to include  the  purchase of
debentures and notes receivable,  secured and unsecured lending and factoring to
micro-cap public and private companies.

NOTE 3 - BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements of the Company have
been prepared in accordance with the accounting principles generally accepted in
the United  States of  America  for  interim  financial  reporting  and with the
instructions  to Form  10-QSB and Item 310 (b) of  Regulation  S-B.  They do not
include all of the information and footnotes  required by accounting  principles
generally  accepted  in the United  States of  America  for  complete  financial
statements.  In the opinion of management,  all adjustments,  consisting only of
normal recurring adjustments, considered necessary for a fair presentation, have
been included in the  accompanying  unaudited  financial  statements.  Operating
results for the periods presented are not necessarily  indicative of the results
that may be expected for the full year.

Since CSI is the surviving entity of the reverse merger,  the financial  reports
include the unaudited  consolidated  balance sheet at September 30, 2005 and the
results of operations  for nine (9) months for CSI and for the period August 25,
2005 through  September 30, 2005 for the Company.  Since CSI was incorporated on
October 22, 2004, there are no results of operations to report for the three (3)
months or nine (9) months ended September 30, 2004.

The unaudited  consolidated financial statements include the accounts of Natural
Nutrition  Inc.,  formerly  CSI Business  Finance,  Inc.,  and its  wholly-owned
subsidiaries.  All significant  intercompany accounts and transactions have been
eliminated in consolidation.

These unaudited  consolidated financial statements should be read in conjunction
with the financial  statements  and  footnotes  for the year ended  December 31,
2004,  which were filed by the Company  with the U.S.  Securities  and  Exchange
Commission  on Form 8-K/A on November 1, 2005.  Other than as  discussed  in the
Explanatory  Note above,  this Form 10-QSB/A does not reflect  events  occurring
after the  filing  of the  Original  Filing  or  modify  or  update  disclosures
(including the exhibits to the Original Filing)  affected by subsequent  events.
Accordingly,  this Form 10-QSB/A should be read in conjunction with our periodic
filings made with the Securities and Exchange Commission  subsequent to the date
of the Original Filing.


                                      -7-
<PAGE>


NOTE 4 - CONVERTIBLE DEBENTURE PAYABLE

Effective September 9, 2005, the Company issued a secured convertible  debenture
(the "Debenture") to Cornell Capital Partners,  LP in the amount of $15,635,199.
This  Debenture  is due on  September  9, 2008 with  interest  accruing  at five
percent  (5%).  Interest  is  due  at  maturity  or  conversion.  On  the  third
anniversary  date of  issuance,  the  Company  has the  option of paying all the
unpaid principal and accrued  interest on the unconverted  debentures or convert
the debentures into common stock. The conversion option is available at any time
until  payment  in full of the  debenture.  Conversion  is  into  shares  of the
Company's common stock at the lesser of (a) one hundred twenty percent (120%) of
the volume  weighted  average  price on September 9, 2005 or (b) eighty  percent
(80%)of the average of the three lowest  volume  weighted  average price days of
the Company's Common Stock for the five (5) days prior to the conversion.

For the period from inception of the Convertible Debenture through September 30,
2005, the amortization of unamortized discount on the Convertible  Debenture was
$8,201,  which has been  classified  as  interest  expense  in the  accompanying
statement of operation.

Related  financing  costs  totaling  $575,000  were  capitalized  and are  being
amortized  over the life of the  debenture.  Amortization  for the  month  ended
September 30, 2005 totaled  $11,027.  Proceeds  from the debenture  were used to
acquire the  $8,500,000  debenture and the $500,000  unsecured  notes  discussed
below,  to pay certain  liabilities of the Company  assumed in the merger and to
provide working capital.

Note 5 - NOTES AND CONVERTIBLE DEBENTURE RECEIVABLE

On September 9, 2005, the Company purchased a portion of a convertible debenture
and related accrued  interest for $8,500,000 and two unsecured notes  receivable
and related accrued interest for $500,000 from Cornell Capital Partners, LP. The
notes bear interest at 5%, which is accrued until maturity on June 30, 2006. The
notes are  convertible,  at the  option of the  Company,  into  common  stock of
Bio-One  Corporation  at a  price  of  $0.75  per  share,  subject  to  standard
anti-dilution   provisions   relating  to  splits,   reverse  splits  and  other
transactions plus a reset provision whereby the conversion price may be adjusted
downward  to a lower  price per share  based on 80% of the average for the three
lowest closing prices for five trading days prior to conversion. The Company has
the right to cause the notes to be converted  into common  stock,  subject to an
ownership limitation of 4.99% of the outstanding stock. Bio-One has the right to
repurchase the Notes at 120% of the face amount.

For the period from acquisition of the convertible  debenture  through September
30, 2005, the  amortization  of  unamortized  premium on the debenture was $832,
which has been netted against interest expense in the accompanying  statement of
operation.

NOTE 6 - CAPITAL

On August 25, 2005,  the Company's  Board of Directors  increased the authorized
shares of Capital  Stock to Five Billion Ten Million  (5,010,000,000)  shares as
follows:

      o     Five  Billion  (5,000,000,000)  shares of common  stock having a par
            value of $0.001 per share; and,

      o     Ten Million  (10,000,000)  shares designated "blank check" preferred
            stock  having a par value of $0.01 per share to be issued  with such
            rights, designations,  preferences and other terms and conditions as
            may be determined  by the Board of Directors,  from time to time and
            at any time, in their sole discretion, without any further action by
            the shareholders.

Previously,  on June 17, 2005, the Company took the following  corporate actions
regarding the creation and  designation of Series A Convertible  Preferred Stock
which were issued on August 25, 2005:

      o     100,000 shares authorized;

      o     Par value is $0.01 per share;

      o     Rank is equal to  common  stock and  junior  to all other  series of
            preferred stock;

      o     Entitled to  dividends  when  declared on common stock on a pro rata
            basis on an as converted basis;

      o     No liquidation, redemption rights or preferences;


      o     Convertible  at anytime at option of holder  into  19,500  shares of
            common stock for each share of Convertible Preferred Stock, Series A
            held; and

      o     Voting  rights are the same as the common stock voting  rights on an
            as if converted basis.


                                      -8-
<PAGE>


As a result of that certain Share  Exchange  Agreement,  which became  effective
August 25,  2005,  the CSI  Shareholder  delivered to the Company the issued and
outstanding  common  stock of CSI in  exchange  for  100,000  shares of Series A
Convertible  Preferred  Stock,  par value $0.01 per share.  The Preferred shares
were subsequently distributed to the shareholders of the CSI Shareholder. If the
Preferred  shareholders  were to convert into common stock as of the date of the
merger, the CSI shareholders would receive  1,950,000,000 shares of common stock
of the Company,  or  ninety-two  and one half percent  (92.5%) of the then to be
issued  and  outstanding  shares of  common  stock of the  Company,  effectively
transferring control.

The Series A Convertible  Preferred  Shareholders  and the holders of the common
stock of the  Company  vote  together  and not as separate  classes.  For voting
purposes the  Preferred  Stock is counted on an "as  converted"  basis,  thereby
giving the Preferred  Stockholders  control of the Company.  The  transaction is
being  accounted for as a reverse  acquisition  since control of the Company has
passed to the shareholders of the acquired company (CSI).

NOTE 7 - DEFERRED INCOME TAXES

The  Company  will file a  consolidated  tax return with its  subsidiaries.  The
Company has a net operating loss carryforward of approximately  $6,160,000 which
will expire in 2024.  The  Company's  net operating  loss  carryforward  will be
subject  to  significant  annual  limitations  which  will  reduce  or defer the
utilization  of the loss as a result of  ownership  change as defined in Section
382 of the Internal Revenue Code.

The net  deferred tax assets that would  result from use of net  operating  loss
carryforwards  discussed  above have been fully  reserved  for in the  financial
statements.

NOTE 8 - CONCENTRATION OF DEBENTURE AND NOTES RECEIVABLE

All of the debenture  receivables and notes receivable (totaling $9,440,952) are
from a single debtor, Bio-One. Bio-One has substantial investments in Canada and
China which secure the debt subject to prior liens of the seller on the Canadian
investment.  Bio-One is in litigation  with the sellers,  who have put Bio-One's
primary operating asset, Interactive Nutrition,  Inc. in the hand's of a private
receiver.  Bio-One  intends  to  vigorously  protect  its  rights and pursue the
sellers for  enforcement  of  Bio-One's  rights  under the  purchase  agreement.
Management  believes  Bio-One will ultimately  prevail in its claims against the
sellers of Interactive Nutrition, Inc.

NOTE 9 - OPTIONS AND WARRANTS

Options to purchase  142,366 shares of the Company's common stock at an exercise
price of $1.31 per share were  outstanding  at September  30, 2005.  The options
expire August 31, 2007.

Warrants  to  purchase  2,000,000  shares of the  Company's  common  stock at an
exercise price of $1.00 expire May 2, 2011. Warrants for the purchase of 100,000
shares of common stock at an exercise price of $0.55 expire July 28, 2008.

NOTE 10 - COMMITMENTS AND CONTINGENCIES

On December 8, 2004 a lawsuit was filed against the Company in the Circuit Court
of the 15th Judicial Court of Palm Beach County. The Plaintiff,  Lester M. Entin
Associates,  is the landlord of the property in which the  Company's  Boca Raton
restaurant was located. The Plaintiff claimed the Company defaulted on its lease
with the Plaintiff. The Plaintiff is seeking $221,304 in damages. As if the date
of the  accompanying  report,  the litigation was on going. The Company believes
that they have adequately reserved for this lawsuit.

Note 11 - DERIVATIVE FINANCIAL INSTRUMENTS

The  derivatives  from  both the  debenture  payable  and  receivable  have been
accounted for in accordance  with SFAS 133 and EITF No. 00-19,  "Accounting  for
Derivative  Financial  Instruments  Indexed  to, and  Potentially  Settled in, a
Company's Own Stock."


                                      -9-
<PAGE>


The Company has identified the following  instruments have derivatives requiring
evaluation and accounting  under the relevant  guidance  applicable to financial
derivatives:

      *     Bio-One Debenture Receivable acquired on 9/9/05 in the face amount
            of $8,500,000

      *     Cornell Debenture Payable issued 9/9/05 in the face amount of
            $15,635,199

The Company has identified the above debentures have embedded derivatives. These
embedded  derivatives  have been  bifurcated  from  their  respective  host debt
contracts and accounted for as derivative  assets or  liabilities  in accordance
with EITF 00-19. When multiple  derivatives exist within the Convertible  Notes,
they have been  bundled  together  as a single  hybrid  compound  instrument  in
accordance with SFAS No. 133  Derivatives  Implementation  Group  Implementation
Issue  No.  B-15,  "Embedded  Derivatives:   Separate  Accounting  for  Multiple
Derivative Features Embedded in a Single Hybrid Instrument."

The embedded  derivatives  within the Convertible Note has been recorded at fair
value at the date of issuance;  and is  marked-to-market  each reporting  period
with changes in fair value  recorded to the Company's  income  statement as "Net
change in fair value of derivatives." As originally filed the Company utilized a
third  party  valuation  firm to develop  the model to fair  value the  embedded
derivatives using a layered discounted  probability-weighted cash flow approach.
The fair value model utilized to value the various  embedded  derivatives in the
convertible note receivable,  comprises multiple probability-weighted  scenarios
under various  assumptions  reflecting the economics of the  Convertible  Notes,
such as the risk-free interest rate, expected Issuer stock price and volatility,
likelihood of conversion  and or redemption,  and likelihood  default status and
timely  registration.  This  model  was  used  by  the  Company  for  additional
derivative valuations required for this restatement.

The fair value of the derivative  instruments  are subject to the changes in the
trading  value of the  Company's or  Bio-One's  common  stock,  as well as other
factors.  As a result,  the Company's  financial  statements  may fluctuate from
quarter-to-quarter  based on  factors,  such as the  price of the  Company's  or
Bio-One's stock at the balance sheet date and the amount of shares  converted by
the note holders. Consequently, our financial position and results of operations
may vary from  quarter-to-quarter  based on conditions  other than our operating
revenues and expenses.

The  conversion  feature,  reset  provision  and the  Company's  optional  early
redemption  right  have been  bundled  together  as a single  compound  embedded
derivative liability, and using a layered discounted  probability-weighted  cash
flow approach, was initially fair valued at $413,603 at September 9, 2005. Using
the same  methodology,  the single compound  embedded  derivative  liability was
valued at $405,385 at September 30, 2005.  For the period from  inception of the
Convertible  Debentures  Payable through  September 30, 2005, the change in fair
value of the  derivative  liability  was a decrease  of  $8,218,  which has been
classified as Other (Income) Expense (Net change in fair value of derivative).

The derivative instrument related to the debenture receivable was initially fair
valued at $33,315 on  acquisition  at  September  9, 2005.  The single  compound
embedded  derivative  asset was valued at $31,936 at September 30, 2005. For the
period from  acquisition of the  Convertible  Debenture  Receivable  through the
September  30,  2005,  the  change in fair value of the  derivative  asset was a
decrease of $1,379,  which has been  classified as Other  (Income)  Expense (Net
change in fair value of derivative).


                                      -10-
<PAGE>


Note 12 - RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS


Natural Nutrition Inc., formerly CSI Business Finance,  Inc., (the "Company") is
filing  this  Amendment  No. 1 to its  Quarterly  Report on Form  10-QSB for the
quarter  ended  September  30,  2005  to  restate  the  financial  results.  The
restatement includes adjustments to:

      o     Correct the overstatement of the number of common shares outstanding
            at September 30, 2005 from 159,226,866 to 157,191,508.  Effective as
            of August 25,  2005,  in  connection  with the  closing of the Share
            Exchange Agreement by and between the Company, CSI Business Finance,
            Inc. (the Texas corporation and now a wholly-owned subsidiary of the
            Company)  and the  shareholders  of CSI,  two (2)  individuals  were
            issued  shares  of  common  stock of the  Company  to pay off  notes
            equaling  $117,660,  a  debenture  equaling  $60,000  and $27,952 of
            accrued interest. In the originally filed Form 10QSB for the quarter
            ended  September  30, 2005 it was reported  159,226,866  shares were
            issued;  however,  only  157,191,508  were ultimately  issued.  This
            restatement  decreased  Common  Stock and the  Retained  Deficit  by
            $2,036.

      o     Remove the beneficial conversion feature previously recorded for the
            convertible  debentures  and  recognize  the effects of the embedded
            derivatives  in the  debentures.  As originally  filed we valued and
            recorded  a  beneficial   conversion  feature  for  the  convertible
            debenture payable.  Subsequent to the original filing, we determined
            both  the  convertible  debenture  receivable  and  the  convertible
            debenture  payable have embedded  derivatives since the total number
            of shares  which can be converted is not a fixed number (see Note 11
            for further discussion).  Therefore,  the following adjustments were
            recorded:

            o     The  adjustment to remove the  beneficial  conversion  feature
                  reduced interest expense by $3,940,000 and reduced  additional
                  paid-in-capital and retained earnings by $3,779,774.

            o     To recognize  the embedded  derivatives  we recorded a $33,315
                  derivative  asset  and  related   debenture   premium  on  the
                  debenture  receivable and a $413,603 derivative  liability and
                  debenture discount on the debenture payable.  Interest expense
                  was increased by $7,369 from the amortization of the debenture
                  premium and  discount  and the fair value of  derivatives  was
                  credited  with  $6,839  of income  from the net  change in the
                  value of the derivative asset and debenture discount.

A summary of the significant effects of the restatement is presented below:

Balance Sheet
--------------------------------------------------------------------------------
                                                  September 30, 2005
                                          ------------------------------
                                           As Reported       As Restated
                                          -------------    -------------
Derivative asset                          $          --    $      31,936

Convertible debenture receivable-net of
debenture premium                             8,500,000        8,467,517

Convertible debenture payable-net of
discounts                                    15,635,199       15,229,797

Derivative liability                                 --          405,385

Common stock                                    159,227          157,191

Additional paid-in-capital                    3,779,774               --

Retained deficit                             (5,069,832)      (1,288,552)

Common shares issued and outstanding        159,226,866      157,191,508


                                      -11-
<PAGE>


Statements of Operations
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                  Nine Months Ended              Three Months Ended
                                                  September 30, 2005             September 30, 2005
                                            ----------------------------    ----------------------------
                                             As Reported     As Restated     As Reported     As Restated
                                            ------------    ------------    ------------    ------------
<S>                                         <C>             <C>             <C>             <C>
Interest expense                            $  4,008,712    $     76,081    $  4,008,712    $     76,081

Net change in fair value of derivatives               --          (6,839)             --          (6,839)

Net loss applicable to common shares          (5,067,935)     (1,128,465)     (5,073,832)     (1,134,362)

Net loss per share for basic and diluted           (0.29)          (0.06)          (0.29)          (0.06)

Weighted shares outstanding for basic and
diluted                                       17,692,763      17,466,612      17,692,763      17,466,612
</TABLE>

Statements of Cash Flows
--------------------------------------------------------------------------------
                                          Nine Months Ended
                                         September 30, 2005
                                    --------------------------
                                    As Reported    As Restated
                                    -----------    -----------
Net loss                            $(5,055,935)   $(1,116,465)

Amortization of deferred expenses        11,027         11,557

Non-cash interest expense             3,940,000             --


ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Introduction

Forward Looking Statements

In  connection  with  the  safe  harbor  provisions  of the  Private  Securities
Litigation  Reform  Act of 1995 (the  "Reform  Act"),  Natural  Nutrition  Inc.,
formerly CSI Business  Finance,  Inc., and its subsidiaries are hereby providing
cautionary  statements  identifying  important  factors  that  could  cause  the
Company's   actual  results  to  differ   materially  from  those  projected  in
forward-looking  statements made herein. Any statements that express, or involve
discussions as to,  expectations,  beliefs,  plans,  objectives,  assumptions of
future events or performance  are not statements of historical  facts and may be
forward-looking.  These  forward-looking  statements  are based  largely  on the
Company's  expectations and are subject to a number of risks and  uncertainties,
including  but  not  limited  to,  economic,  competitive,   regulatory,  growth
strategies,  available  financing and other factors discussed  elsewhere in this
report  and in  documents  filed by the  Company  with the U.S.  Securities  and
Exchange  Commission  ("SEC").  Many of these  factors are beyond the  Company's
control.  Actual  results  could  differ  materially  from  the  forward-looking
statements  made.  In light of these  risks and  uncertainties,  there can be no
assurance  that  the  results  anticipated  in the  forward-looking  information
contained in this report will, in fact, occur.


                                      -12-
<PAGE>


      Any  forward-looking  statement  speaks  only as of the date on which such
statement  is made,  and the  Company  undertakes  no  obligation  to update any
forward-looking statement or statements to reflect events or circumstances after
the date on  which  such  statement  is made or to  reflect  the  occurrence  of
unanticipated  events.  New  factors  emerge  from  time to  time  and it is not
possible for  management to predict all of such  factors,  nor can it assess the
impact of each such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements.

The Merger

      On August 25, 2005, the Company, a Florida corporation  (formerly known as
Health Express USA,  Inc.)  completed the closing of that certain Share Exchange
Agreement by and between the  Company,  CSI Business  Finance,  Inc.  (the Texas
corporation and now wholly-owned subsidiary of the Company herein referred to as
"CSI") and the shareholder of CSI (the "CSI Shareholder".)

      On  August  25,  2005,  the  Company  effectively  exchanged  with the CSI
Shareholder the issued and outstanding common stock of CSI for 100,000 shares of
Series A Convertible Preferred Stock, par value $0.01 per share, of the Company,
and CSI  became a  wholly-owned  subsidiary  of the  Company.  Each share of the
Company's  Series A Preferred Stock is convertible  into 19,500 shares of common
stock of the Company. The Preferred shares were subsequently  distributed to the
shareholders  of  the  CSI  Shareholder.  In  addition  at  the  exchange  date,
110,206,883  shares of common  stock of the Company  were issued to settle notes
and debentures. If the preferred shareholders were to convert to common stock as
of the date of the merger, they would hold 1,950,000,000  shares of the Company,
or ninety-two and one half percent (92.5%) of the issued and outstanding  shares
of common stock of the  Company.  This  conversion  would result in the Series A
Preferred Shareholders effectively controlling the Company.

      The Series A  Convertible  Preferred  Shareholders  and the holders of the
common stock of the Company vote together and not as separate  classes,  and the
Preferred  stock shall be counted on "as  converted"  basis,  thereby giving the
Preferred  Shareholders  control  of  the  Company.  The  transaction  is  being
accounted for as a reverse  acquisition  since control of the Company has passed
to the shareholders of the acquired company (CSI).

      Since CSI is the  surviving  entity of the reverse  merger,  the financial
reports  include the  consolidated  balance  sheet at September 30, 2005 and the
results of operations  for nine (9) months for CSI and for the period August 25,
2005 through  September 30, 2005 for the Company.  Since CSI was incorporated on
October 22, 2004, there are no results of operations to report for the three (3)
months or nine (9) months ended September 30, 2004.

Plan of Operation

      The  Company  intends  to  expand  its  leasing,   lending  and  factoring
activities to micro-cap public and private companies.  The Company believes this
market is  underserved.  Management also intends to pursue purchase of notes and
stock  in the  micro-cap  public  companies  under  distress  situation  for the
possibility of gains on resale of stock and collection or resale of notes.

      Management  of the  Company  mitigates  risk in lending  to this  business
segment by either  obtaining  personal  guarantees from individuals of net worth
which are  adequate  to repay the  liability  in the event of  default,  pledged
assets  that,  when  liquidated,  have a reasonable  probability  of proceeds to
retire the liability,  or, in the example of public company finance,  conversion
features at a  substantial  discount to the market in the event of default  that
would allow the Company adequate  proceeds from the sale of the borrower's stock
to repay the liability to the Company.

Results Of Operations

Results Of Operations For The Nine (9) Months Ending September 30, 2005

      Revenues

      Lease income of $60,649 is from CSI financing  leases on  automobiles  and
equipment.  Fee income of $81,492  represents fees received for the non-recourse
sales of completed  lease packages to financial  institutions.  Trading gains of
$33,898  primarily  represents  third quarter realized gains on sales of trading
securities.

      Operating Expenses

      Salaries  and  benefits  of  $230,803  represent  direct  salaries  and an
allocation of administrative  salaries,  and includes  approximately $167,000 in
bonuses to officers and employees in September 2005.

      Professional fees of $56,464 include legal fees of approximately  $24,000,
amortization of deferred financing costs of $11,027, accounting and other.


                                      -13-
<PAGE>


      Other Income And Expense

      Interest  expense  of  $76,801  relates  to the  convertible  subordinated
 debenture.

      Other expense of $34,557  includes  $40,000  related to the  redemption of
preferred  shares  of  CSI  in  July  2005,  and  is  net  of  other  income  of
approximately $9,000.

      Interest income relates to the convertible  debenture and notes receivable
from Bio-One acquired in September 2005.

      Merger expenses of $876,150  primarily  represent  liabilities  assumed in
excess of assets acquired in the merger.

Results Of Operations For The Three (3) Months Ending September 30, 2005

      Revenues

      Lease income of $19,338 is from CSI financing  leases on  automobiles  and
equipment.  Fee income of $34,379  represents fees received for the non-recourse
sales of completed  lease packages to financial  institutions.  Trading gains of
$33,898 primarily represent realized gains on sales of trading securities.

      Operating Expenses

      Salaries  and  benefits  of  $198,697  represent  direct  salaries  and an
allocation of administrative  salaries,  and include  approximately  $167,000 in
bonuses to officers and employees in September 2005.

      Professional fees of $45,667 includes legal fees of approximately $24,000,
amortization of deferred financing costs of $11,027, accounting and other.

      Other Income And Expense

      Interest  expense  of  $76,081  relates  to the  convertible  subordinated
 debenture.

      Other expense of $30,547  includes  $40,000  related to the  redemption of
preferred  shares  of  CSI  in  July  2005,  and  is  net  of  other  income  of
approximately $9,000.

      Interest income relates to the convertible  debenture and notes receivable
from Bio-One acquired in September 2005.

      Merger expenses of $876,150  primarily  represent  liabilities  assumed in
excess of assets acquired in the merger.

Liquidity And Capital Resources

      As of September  30, 2005,  the Company had  approximately  $4,774,914  in
cash.  This amount of available cash is sufficient to satisfy the Company's need
for working capital for the short-term.

      Cash  used in  operating  activities  during  the  nine (9)  months  ended
September  30, 2005 was  $558,888.  The cash used in  operating  activities  was
mainly a result of the Company's  investment in marketable  securities and notes
receivable.

      Cash used in  investing  activities  was  $26,037  for the nine (9) months
ended  September  30, 2005,  representing  primarily the change in minimum lease
payments receivable.

      Cash  provided by financing  activities  was  $5,359,839  for the nine (9)
months ended  September 30, 2005,  representing  net proceeds of $5,371,839 from
issuance  of a  convertible  subordinated  debenture,  net of $12,000  preferred
dividends paid.


                                      -14-
<PAGE>


Critical Accounting Policies And Estimates

      Management's  discussion  and  analysis  of our  financial  condition  and
results of  operations  are based upon our  consolidated  financial  statements,
which have been  prepared in accordance  with  accounting  principles  generally
accepted in the United States of America.  The  preparation  of these  financial
statements  requires  that we make  estimates  and  judgments  that  affect  the
reported  amounts of assets,  liabilities,  revenues and  expenses,  and related
disclosure of  contingent  assets and  liabilities.  At each balance sheet date,
management evaluates its estimates,  including but not limited to, those related
to accrued  liabilities and the valuation  allowance  offsetting deferred income
taxes.  The Company  also  reviews its  investments  in  marketable  securities,
convertible  debentures and notes  receivable for possible  impairment  whenever
events  indicate that their carrying value may not be  recoverable.  We base our
estimates on historical  experience  and on various other  assumptions  that are
believed to be reasonable  under the  circumstances.  Actual  results may differ
from these estimates under  different  assumptions or conditions.  The estimates
and critical  accounting policies that are most important in fully understanding
and evaluating our financial  condition and results of operations  include those
listed above.

Revenue Recognition

      The Company  follows  the  guidance of the U.S.  Securities  and  Exchange
Commission's  Staff  Accounting  Bulletin No. 104 for revenue  recognition.  The
Company  records  revenue when  persuasive  evidence of an  arrangement  exists,
services have been rendered or product delivery has occurred, the sales price to
the customer is fixed or determinable, and collectibility is reasonably assured.

ITEM 3. CONTROLS AND PROCEDURES

(A)   Evaluation of Disclosure Controls and Procedures

      As of the  end  of the  period  covered  by  this  report,  the  Company's
management  carried out an  evaluation,  under the  supervision of the Company's
Chief Executive  Officer and Chief Financial Officer of the effectiveness of the
design  and  operation  of the  Company's  system  of  disclosure  controls  and
procedures  pursuant to the  Securities  and Exchange  Act,  Rule  13a-15(e) and
15d-15(e) under the Exchange Act).  Based upon that  evaluation,  and because of
the  restatement  on this Form 10-QSB/A due to complex  accounting  issues,  the
Chief Executive Officer and Chief Financial Officer concluded that the Company's
disclosure  controls and procedures  were not effective,  as of the date of that
evaluation,  for the purposes of recording,  processing,  summarizing and timely
reporting of material  information  required to be disclosed in reports filed by
the Company under the Securities Exchange Act of 1934.

(B)   Changes in Internal Controls over Financial Reporting

      There were no changes in internal  controls over financial  reporting that
occurred  during the three months ended  September 30, 2005 that have materially
affected,  or are reasonably likely to materially  effect,  our internal control
over financial reporting.

      In connection with the audit of our Consolidated  Financial Statements for
the fiscal year ended  December  31, 2005,  our  independent  registered  public
accounting  firm informed us that we had significant  deficiencies  constituting
material weaknesses as defined by the standards of the Public Company Accounting
Oversight  Board,  which had been identified in connection with the audit of our
Consolidated Financial Statements for the fiscal year ended December 31, 2005.

      The  weaknesses  in  question  were  detected  during  the  audit  of  our
consolidated  financial  statements for the fiscal year ended December 31, 2005,
which audit occurred in February through March 2006.

      The weaknesses  were detected in the routine course of the audit review of
accounting for certain non-routine transactions.

      The  specific  problems  identified  by  the  auditor  were  (1)  lack  of
segregation of duties  necessary to maintain proper checks and balances  between
functions, (2) failure of internal personnel to adequately communicate the scope
and  nature  of  non-routine  transactions,  and  (3)  application  of  improper
accounting  principles to financial  derivatives.  The absence of qualified full
time accounting  personnel was a contributing  factor to the problems identified
by the auditor. The specific circumstances giving rise to the weaknesses include
utilizing  the  services  of  contract  accountants  on a part time basis in the
absence of  internal  accounting  personnel.  As a result of the absence of full
time  in-house  accounting  personnel  and the failure of in-house  personnel to
adequately communicate information to the outside contract accountants,  certain
journal  entries  required  during 2004 and 2005 were not made until the time of
the audit when the need for such entries was identified by the auditor.

      As a result of our review of the items identified by our auditors, we have
concluded that our previous derivative accounting policies were incorrect.

      In light of the above,  we have  determined  to restate  our  consolidated
financial statements for the third quarter of 2005 to correct our accounting for
derivatives.

      Further,  based  on the  material  weaknesses  described  herein,  we have
concluded that our internal controls over financial reporting were not effective
at the end of the period covered by this report. More specifically,  our failure
to maintain effective controls over the selection, application and monitoring of
our accounting  policies to assure that certain  transactions were accounted for
in  conformity  with  generally  accepted  accounting  principles  resulted in a
failure  during  2005 to  record an  appropriate  derivative  liability,  deemed
interest  expense  associated with the derivative  liability and related charges
associated with changes in the value of embedded  derivatives,  arising from the
issuance during 2005.


                                      -15-
<PAGE>

                                     PART II
                                OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS

      On December 8, 2004 a lawsuit was filed against the Company in the Circuit
Court of the 15th Judicial Court of Palm Beach County. The Plaintiff,  Lester M.
Entin  Associates,  is the landlord of the property in which the Company's  Boca
Raton restaurant was located. The Plaintiff claimed the Company defaulted on its
lease with the  Plaintiff.  The  Plaintiff is seeking  $221,304 in damages.  The
Lawsuit was settled in December, 2005 for approximately $130,000.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

      On August 25, 2005, in connection  with the closing of the Share  Exchange
Agreement by and between the  Company,  CSI Business  Finance,  Inc.  (the Texas
corporation  and now a  wholly-owned  subsidiary  of the  Company,  also  herein
referred to as "CSI") and the  shareholders  of CSI,  two (2)  individuals  were
issued an aggregate  108,171,525 shares (a restated decrease from the originally
reported  110,206,883  shares--representing  a difference  between the number of
shares  recorded  at the time of  merger  and the date the  actual  shares  were
issued) of common  stock of the Company to pay off notes  equaling  $117,660,  a
debenture equaling $60,000 and $27,952 of accrued interest.

Effective   September  9,  2005,  the  Company  issued  a  $15,635,199   secured
convertible  debenture (the  "Debenture") to Cornell Capital  Partners,  LP. The
Debenture  is due on September  9, 2008 with  interest  accruing at five percent
(5%).  Interest on the Debenture is due at maturity or conversion.  On the third
anniversary  date of  issuance,  the  Company  has the  option of paying all the
unpaid  principal  and  accrued  interest  on  the  unconverted   debentures  or
converting the debentures into stock. The conversion  option is available at any
time until  payment in full of the  Debenture.  Conversion is into shares of the
Company's common stock at the lesser of (a) one hundred twenty percent (120%) of
the volume  weighted  average  price on September 9, 2005 or (b) eighty  percent
(80%)of the average of the three lowest  volume  weighted  average price days of
the Company's Common Stock for the five (5) days prior to the conversion.


ITEM 3. DEFAULT UPON SENIOR SECURITIES

None.


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.


ITEM 5. OTHER INFORMATION

None.


                                      -16-
<PAGE>


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

      (a)   Exhibits:
<TABLE>
<CAPTION>


EXHIBIT NO.       DESCRIPTION                                        LOCATION
-----------       -----------                                        --------

<S>               <C>                                                <C>
3.1               Articles of Incorporation, as amended              Incorporated by reference to Exhibit 2 to Form 10-SB as
                                                                     filed with the U.S. Securities and Exchange Commission
                                                                     on October 6, 1999

3.2               Articles of Amendment to Articles of               Incorporated by reference to Exhibit 3.1 to the
                  Incorporation                                      Company's Current Report on Form 8-K as filed with the
                                                                     U.S. Securities and Exchange Commission on August 30, 2005

3.3               Bylaws                                             Incorporated by reference to Exhibit 3(a) to Form 10-SB
                                                                     as filed with the U.S. Securities and Exchange
                                                                     Commission on October 6, 1999

3.4               Articles of Incorporation of Healthy Bites         Incorporated by reference to Exhibit 3(b) to the
                  Grill of Boca, Inc.                                Company's Quarterly Report on Form 10-QSB as filed with
                                                                     the U.S. Securities and Exchange Commission on August
                                                                     13, 2001

4.1               Warrants for 38,000 shares issued to Francorp,     Incorporated by reference to Exhibit 4 to the Company's
                  Inc.                                               Quarterly Report on Form 10-QSB as filed with the U.S.
                                                                     Securities and Exchange Commission on August 13, 2001

4.2               Warrants for 2,000,000 shares issued to Rider      Incorporated by reference to Exhibit 4 to the Company's
                  Insurance Company                                  Quarterly Report on Form 10-QSB as filed with the U.S.
                                                                     Securities and Exchange Commission on August 13, 2001

4.3               Certificate of Designation of Series A             Incorporated by reference to Exhibit 3.2 to the
                  Convertible Preferred Stock of the Company         Company's Current Report on Form 8-K as filed with the
                                                                     U.S. Securities and Exchange Commission on August 30, 2005

10.1              Lease - Healthy Bites Grill of Boca, Inc.          Incorporated by reference to Exhibit 10 to the Company's
                                                                     Quarterly Report on Form 10-QSB as filed with the U.S.
                                                                     Securities and Exchange Commission on May 14, 2001

10.2              Equity Line of Credit Agreement, dated March       Incorporated by reference to Exhibit 10.19 to the
                  13, 2003, by and between the Company and           Company's Annual Report on Form 10-KSB, as amended, as
                  Cornell Capital Partners, LP                       filed with the U.S. Securities and Exchange Commission
                                                                     on April 24, 2003

10.3              Registration Rights Agreement, dated March 13,     Incorporated by reference to Exhibit 10.20 to the
                  2003, by and between the Company and Cornell       Company's Annual Report on Form 10-KSB as filed with the
                  Capital Partners, LP                               U.S. Securities and Exchange Commission on March 26, 2003

10.4              Escrow Agreement, dated March 13, 2003, by and     Incorporated by reference to Exhibit 10.21 to the
                  among the Company, Cornell Capital Partners,       Company's Annual Report on Form 10-KSB as filed with the
                  LP, Butler Gonzalez, LP                            U.S. Securities and Exchange Commission on March 26, 2003

10.5              Securities Purchase Agreement, dated January       Incorporated by reference to Exhibit 10.22 to the
                  17, 2003, by and between the Company and the       Company's Annual Report on Form 10-KSB as filed with the
                  Buyers listed therein                              U.S. Securities and Exchange Commission on March 26, 2003

10.6              Escrow Agreement, dated January 17, 2003, by       Incorporated by reference to Exhibit 10.23 to the
                  and among the Company, the Buyers listed           Company's Annual Report on Form 10-KSB as filed with the
                  therein and Butler Gonzalez, LP                    U.S. Securities and Exchange Commission on March 26, 2003

10.7              Debenture, dated January 17, 2003, by and          Incorporated by reference to Exhibit 10.24 to the
                  between the Company and Cornell                    Company's Annual Report on Form 10-KSB as filed with the
                  Capital Partners, LP                               U.S. Securities and Exchange Commission on March 26, 2003


10.8              Investors Registration Rights Agreement, dated     Incorporated by reference to Exhibit 10.25 to the
                  March 13, 2003, by and between the Company and     Company's Annual Report on Form 10-KSB as filed with the
                  the Investors listed therein                       U.S. Securities and Exchange Commission on March 26, 2003

10.9              Placement Agent Agreement, dated March 13,         Incorporated by reference to Exhibit 10.26 to the
                  2003, by and among the Company, NT Capital         Company's Annual Report on Form 10-KSB as filed with the
                  Equities, Ltd. and Cornell Partners LP             U.S. Securities and Exchange Commission on March 26, 2003

10.10             Lease Modification - Health Bites Grill of         Incorporated by reference to Exhibit 10.27 to the
                  Boca, Inc.                                         Company's Annual Report on Form 10-KSB as filed with the U.S.
                                                                     Securities and Exchange Commission on March 29, 2004
</TABLE>


                                      -17-
<PAGE>


<TABLE>
<CAPTION>
EXHIBIT NO.       DESCRIPTION                                        LOCATION
-----------       -----------                                        --------
<S>               <C>                                                <C>
10.11             Promissory Note issued by the Company to           Incorporated by reference to Exhibit 10.29 to the
                  Cornell Capital Partners in an amount equal to     Company's Annual Report on Form 10-KSB as filed with the
                  $175,000                                           U.S. Securities and Exchange Commission on March 20, 2005

10.12             Secured Promissory Note, dated March 9, 2005,      Incorporated by reference to Exhibit 99.1 to the
                  issued by the Company to AIM American Mortgage,    Company's Current Report on Form 8-K as filed with the
                  Inc.                                               U.S. Securities and Exchange Commission on March 11, 2005

10.13             Settlement Agreement with Mutual Releases,         Incorporated by reference to Exhibit 10.1 to the
                  dated June 15, 2005, by and among the CSI          Company's Current Report on Form 8-K as filed with the
                  Business Finance, Inc., Health Express             U.S. Securities and Exchange Commission on June 17, 2005
                  Franchise Company, The Myrick Corp., The Junie
                  Corp. and Susan Greenfield

10.14             Settlement Agreement with Mutual Releases,         Incorporated by reference to Exhibit 10.1 to the
                  dated June 15, 2005, by and between CSI            Company's Current Report on Form 8-K as filed with the
                  Business Finance, Inc. and Charles D. Bleiwise     U.S. Securities and Exchange Commission on June 17, 2005

10.15             Share Exchange Agreement, dated June 17, 2005,     Incorporated by reference to Exhibit 99.1 to the
                  by and Health Express USA, Inc., CSI Business      Company's Current Report on Form 8-K as filed with the
                  Finance, Inc. (the Texas corporation, or "CSI")    U.S. Securities and Exchange Commission on August 30, 2005
                  and the shareholders of CSI

10.16             Amendment No. 1 to the Share Exchange              Incorporated by reference to Exhibit 99.2 to the
                  Agreement, dated August 5, 2005, by and among      Company's Current Report on Form 8-K as filed with the
                  CSI Business Finance, Inc. (the Texas              U.S. Securities and Exchange Commission on August 30, 2005
                  Corporation, or "CSI") and the shareholders of
                  CSI

10.17             Securities Purchase Agreement, dated September     Incorporated by reference to Exhibit 99.1 to the
                  9, 2005, by and between the Company and Cornell    Company's Current Report on Form 8-K as filed with the
                  Capital Parters, LP                                U.S. Securities and Exchange Commission on September 13, 2005

10.18             Security Agreement, dated September 9, 2005, by    Incorporated by reference to Exhibit 99.2 to the
                  and between the Company and Cornell Capital        Company's Current Report on Form 8-K as filed with the
                  Parters, LP                                        U.S. Securities and Exchange Commission on September 13, 2005

10.19             Investor Registration Rights Agreement, dated      Incorporated by reference to Exhibit 99.3 to the
                  September 9, 2005, by and between the Company      Company's Current Report on Form 8-K as filed with the
                  and Cornell Capital Parters, LP                    U.S. Securities and Exchange Commission on September 13, 2005

10.20             Convertible Debenture, dated September 9, 2005,    Incorporated by reference to Exhibit 99.4 to the
                  issued by the Company to Cornell Capital           Company's Current Report on Form 8-K as filed with the
                  Parters, LP                                        U.S. Securities and Exchange Commission on September 13, 2005

10.21             Escrow Agreement, dated September 9, 2005, by      Incorporated by reference to Exhibit 99.5 to the
                  and among the Company, Cornell Capital Parters,    Company's Current Report on Form 8-K as filed with the
                  LP and David Gonzalez, Esq.                        U.S. Securities and Exchange Commission on September 13, 2005

10.22             Assignment Agreement, dated September 9, 2005,     Incorporated by reference to Exhibit 99.6 to the
                  by and among the Company, Cornell Capital          Company's Current Report on Form 8-K as filed with the
                  Parters, LP and Bio-One Corporation                U.S. Securities and Exchange Commission on September 13, 2005

10.23             Collateral Assignment Agreement, dated             Incorporated by reference to Exhibit 99.7 to the
                  September 9, 2005, by and between the Company      Company's Current Report on Form 8-K as filed with the
                  and Cornell Capital Parters, LP                    U.S. Securities and Exchange Commission on September 13, 2005

14.1              Code of Ethics                                     Incorporated by reference to Exhibit 14.1 to the
                                                                     Company's Annual Report on Form 10-KSB as filed with the
                                                                     U.S. Securities and Exchange Commission on March 29, 2004
</TABLE>


                                      -18-
<PAGE>


<TABLE>
<CAPTION>

EXHIBIT NO.       DESCRIPTION                                        LOCATION
-----------       -----------                                        --------
<S>               <C>                                                <C>
16.1              Letter, dated October 31, 2005, from Salberg &    Incorporated by reference to Exhibit 99.1 to the
                  Company, P.A. to the Company regarding change      Company's Current Report on Form 8-K as filed with the
                  in the Compan's  independent registered public     U.S. Securities and Exchange Commission on November 2, 2005
                  accounting firm

31.1              Certification by Chief Executive Officer           Provided herewith
                  pursuant to 15 U.S.C. Section 7241, as adopted
                  pursuant to Section 302 of the Sarbanes-Oxley
                  Act of 2002

31.2              Certification by Chief Financial Officer           Provided herewith
                  pursuant to 15 U.S.C. Section 7241, as adopted
                  pursuant to Section 302 of the Sarbanes-Oxley
                  Act of 2002

32.1              Certification by Chief Executive Officer           Provided herewith
                  pursuant to 18 U.S.C. Section 1350, as adopted
                  pursuant to Section 906 of the Sarbanes-Oxley
                  Act of 2002

32.2              Certification by Chief Financial Officer           Provided herewith
                  pursuant to 18 U.S.C. Section 1350, as adopted
                  pursuant to Section 906 of the Sarbanes-Oxley
                  Act of 2002
</TABLE>



      (b) Reports on Form 8-K:

      On August 30, 2005 the Company filed a Current Report on Form 8-K with the
U.S.  Securities  and Exchange  Commission  announcing  the  completion  of that
certain Share  Exchange  Agreement,  entered into on June 17, 2005, by and among
the Company,  CSI  Business  Finance,  Inc.  (the Texas  corporation  and herein
referred to as "CSI") and the  shareholders of CSI. The Company filed an amended
current report on November 1, 2005 to include  certain  financial  statements of
CSI Business Finance, Inc.

      On September 13, 2005, the Company filed a Current Report on Form 8-K with
the U.S. Securities and Exchange Commission  announcing that it had entered into
a Securities Purchase Agreement with Cornell Capital Partners, LP.


                                      -19-
<PAGE>


                                   SIGNATURES

      Pursuant  to the  requirements  of Section  13 or 15(d) of the  Securities
Exchange Act of 1934,  Natural Nutrition Inc., has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 3, 2006              NATURAL NUTRITION, INC.


                                    By: /s/ Timothy J. Connolly
                                        -----------------------
                                        Name:  Timothy J. Connolly
                                        Title: Chief Executive Officer

                                      -20-